Description
Test Suspension is unesterified testosterone in aqueous vehicle as a microcrystal suspension. The crystal form delivers a mixed release profile - the dissolved portion acts immediately like Test Base, the undissolved crystals serve as a mini-depot dissolving over 1-2 days.
Per study reports this delivery form yields faster peak values than Propionate but somewhat longer clearance than pure Test Base in oil. The effective half-life is approximately 24 hours, requiring daily injections or research protocols every 1-2 days.
The aqueous formulation has two important properties: first, it can - unlike oil esters - be combined with other water-soluble compounds in one syringe (e.g., aqueous amino-acid cocktails in acute pharmacology studies). Second, post-injection inflammation is typically higher than with oily formats because the microcrystals mechanically irritate the tissue.
In classical anabolic research literature Suspension is used in pre-workout pharmacology and pre-contest studies where rapid action and relatively fast clearance matter.
You can order Test Suspension as an aqueous injection suspension in 10-vial packs at 100mg/ml.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
Test Suspension shares the risk profile of all testosterone forms - the aqueous microcrystal suspension additionally brings a pronounced injection-site burden.
Documented in studies and the application literature:
- Estrogen conversion: unesterified testosterone aromatizes to estradiol. Water retention, blood pressure rise and at higher doses gynecomastia risk are documented.
- Suppression of endogenous production: exogenous testosterone throttles the body’s own production via the HPTA axis. Testicular atrophy and reduced fertility are documented.
- Cardiovascular: studies describe unfavorable shifts in the lipid profile (HDL falls), elevated hematocrit and an associated thrombosis risk.
- Post-injection inflammation: the microcrystals mechanically irritate the tissue, post-injection inflammation is typically higher than with oily formats. Daily injections increase the burden further.
Baseline bloodwork before, during and after a research protocol is strongly advised. This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- Therapy with Aqueous Suspensions of Testosterone - The Journal of Clinical Endocrinology and Metabolism 1946, Sevringhaus & Sikkema: Early clinical work on aqueous testosterone suspension - documents the action profile of this ester-free delivery form.
- Intramuscularly injected long-acting testosterone-cholesterol prodrug suspension with three different particle sizes: extended in vitro release and enhanced in vivo safety - Drug Delivery and Translational Research 2023, Li et al: Shows in a suspension format how the crystal particle size governs the release profile and tissue tolerability.
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men - New England Journal of Medicine 1996, Bhasin et al: Foundational study on the testosterone dose-response relationship.
- Pharmacology of testosterone replacement therapy preparations - Translational Andrology and Urology 2016, Shoskes et al: Pharmacokinetics and adverse-effect review of the common testosterone delivery forms.
